Intention-to-Treat Analysis of


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
10 2019
Historique:
received: 09 12 2018
accepted: 11 02 2019
pubmed: 10 3 2019
medline: 14 4 2020
entrez: 10 3 2019
Statut: ppublish

Résumé

Biochemical recurrence (BCR) after prostate cancer surgery is common, even after additional salvage radiotherapy. BCR might be explained by target miss. Improved diagnostic accuracy provided by PET could potentially circumvent this therapeutic gap. Therefore, we evaluated consecutive

Identifiants

pubmed: 30850491
pii: jnumed.118.224543
doi: 10.2967/jnumed.118.224543
doi:

Substances chimiques

Gallium Isotopes 0
Gallium Radioisotopes 0
Membrane Glycoproteins 0
Organometallic Compounds 0
gallium 68 PSMA-11 0
methyl carbon-11 choline 0
Choline N91BDP6H0X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1359-1365

Informations de copyright

© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Johannes Schwenck (J)

Department of Nuclear Medicine and Clinical Nuclear Medicine, Eberhard Karls University, Tübingen, Germany.
Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.

Susann-Cathrin Olthof (SC)

Department of Diagnostic and Interventional Radiology, Eberhard Karls University, Tübingen, Germany.

Christina Pfannenberg (C)

Department of Diagnostic and Interventional Radiology, Eberhard Karls University, Tübingen, Germany.

Gerald Reischl (G)

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.

Daniel Wegener (D)

Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany; and.

Jolanta Marzec (J)

Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany; and.

Jens Bedke (J)

Department of Urology, Eberhard Karls University, Tübingen, Germany.

Arnulf Stenzl (A)

Department of Urology, Eberhard Karls University, Tübingen, Germany.

Konstantin Nikolaou (K)

Department of Diagnostic and Interventional Radiology, Eberhard Karls University, Tübingen, Germany.

Christian la Fougère (C)

Department of Nuclear Medicine and Clinical Nuclear Medicine, Eberhard Karls University, Tübingen, Germany.

Daniel Zips (D)

Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany; and.

Arndt-Christian Müller (AC)

Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany; and arndt-christian.mueller@med.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH